Keyphrases
Therapeutic Potential
100%
Pulmonary Hypertension
100%
Endothelin Receptor Antagonist
100%
Nitric Oxide Donors
100%
Vasodilator
50%
Relative Contribution
16%
Receptor Antagonist
16%
Cardiovascular Disease
16%
Etiology
16%
Blood Flow
16%
Structural Change
16%
Acute Lung Injury
16%
New Therapies
16%
Pulmonary Circulation
16%
Scleroderma
16%
Congestive Heart Failure
16%
Congenital Heart Disease
16%
Chronic Obstructive Pulmonary Disease
16%
Pulmonary Disease
16%
Vascular Structure
16%
Pharmaceutical Companies
16%
Exhaled Nitric Oxide
16%
Left-handed
16%
Calcium Channel Blockers
16%
Right Heart Failure
16%
Connective Tissue Disease
16%
Vascular Tone
16%
Three-class
16%
Pulmonary Vascular Resistance
16%
Mitral Stenosis
16%
Pulmonary Hypertension Treatment
16%
Anticoagulant Drugs
16%
Oral Calcium
16%
Prostaglandin Analogs
16%
Flow Obstruction
16%
Development Status
16%
Aerosolised
16%
Medicine and Dentistry
Pulmonary Hypertension
100%
Nitric Oxide Donor
100%
Endothelin Receptor Antagonist
100%
Vasodilator Agent
42%
Disease
28%
Cardiovascular Disease
14%
Blood Flow
14%
Receptor Antagonist
14%
Nitric Oxide
14%
Silo-Filler's Disease
14%
Pulmonary Circulation
14%
Persistent Truncus Arteriosus
14%
Blood Vessel
14%
Obstruction
14%
Hemodynamic
14%
Calcium Channel Blocking Agent
14%
Chronic Obstructive Pulmonary Disease
14%
Congestive Heart Failure
14%
Acute Lung Injury
14%
Heart Right Ventricle Failure
14%
Connective Tissue Disease
14%
Blood Vessel Tone
14%
Lung Vascular Resistance
14%
Antithrombotic
14%
Scleroderma
14%
Mitral Valve Stenosis
14%
Prostacyclin Derivative
14%
Pharmacology, Toxicology and Pharmaceutical Science
Nitric Oxide Donor
100%
Pulmonary Hypertension
100%
Endothelin Receptor Antagonist
100%
Vasodilator Agent
42%
Disease
28%
Scleroderma
14%
Acute Lung Injury
14%
Receptor Antagonist
14%
Nitric Oxide
14%
Congestive Heart Failure
14%
Chronic Obstructive Lung Disease
14%
Lung Disease
14%
Anticoagulant Agent
14%
Calcium Channel Blocker
14%
Obstruction
14%
Congenital Heart Disease
14%
Heart Right Ventricle Failure
14%
Mitral Valve Stenosis
14%
Connective Tissue Disease
14%
Prostacyclin Derivative
14%
Cardiovascular Disease
14%